Reuters: Regulatory News: CORRECTED-Icahn slams Forest Labs over FDA warning letter

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

CORRECTED-Icahn slams Forest Labs over FDA warning letter Aug 13th 2012, 22:55 Mon Aug 13, 2012 6:55pm EDT Aug 13 (Reuters) - Investor Carl Icahn expressed concerns about Forest Laboratories Inc receiving its second warning letter from U.S health regulators for unethical practices by the drugmaker's sales representatives. Icahn is waging a proxy fight to elect four directors to Forest's 10-member board at its annual meeting on Aug. 15 after failing in a similar effort last year. On Aug. 1, Forest received a warning letter from the Food and Drug Administration, regarding a violation of promotional practices for the company's pulmonary drug Daliresp. It had received a similar letter last year related to unethical sales practices for selling fibromyalgia drug Savella. "Forest is one of the only (few) companies lax enough to receive multiple warning letters while subject to a Corporate Integrity Agreement," Icahn said in a statement. Shares of the company closed at $33.95 on the New York Stock Exchange on Monday. (Reporting by Balaji Sridharan in Bangalore, Editing by Saumyadeb Chakrabarty)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions